Your Location:
Home >
Browse articles >
Therapeutic effect of 5-FC on YCD modified murine P388 leukemia in vivo
Updated:2026-03-12
    • Therapeutic effect of 5-FC on YCD modified murine P388 leukemia in vivo

    • Military Medical Research   Vol. 0, Issue 1, Pages: 22-26(2005)
    • CLC: R733.7
    • Published:2005

    Scan QR Code

  • Therapeutic effect of 5-FC on YCD modified murine P388 leukemia in vivo[J]. Military Medical Research2005, 0(1): 22-26. DOI:

  •  
  •  
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

0

Views

31

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research
Ionizable drug delivery systems for efficient and selective gene therapy
Novel gene therapy for rheumatoid arthritis with single local injection: adeno-associated virus-mediated delivery of A20/TNFAIP3
An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening

Related Author

Xiao Yang
Jian Wang
Jing-Ping Xu
Jun Wang
Zhen-Hua Li
Yuan-Yu Huang
Yu-Peng Li
Ji-Bin Guan

Related Institution

Yaneng BIOScience (Shenzhen) Co., Ltd.
State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences, Beijing Institute of Lifeomics
Department of Health Technology and Informatics, the Hong Kong Polytechnic University
Department of Laboratory Medicine, Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan Hospital, Southern Medical University
Advanced Research Institute of Multidisciplinary Science, School of Life Science, School of Medical Technology, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Beijing Institute of Technology
0